# Combined Use of Povidone-Iodine and Rifampicin in Hair Transplantation

> **NCT07155408** · NA · COMPLETED · sponsor: **Elif Asena KANTARCI** · enrollment: 65 (actual)

## Conditions studied

- Androgenetic Alopecia
- Wound Healing

## Interventions

- **DRUG:** Povidone-Iodine 10%
- **DRUG:** Povidone-Iodine + Rifampicin

## Key facts

- **NCT ID:** NCT07155408
- **Lead sponsor:** Elif Asena KANTARCI
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-02
- **Primary completion:** 2022-05-15
- **Final completion:** 2022-06-22
- **Target enrollment:** 65 (ACTUAL)
- **Last updated:** 2025-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07155408

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07155408, "Combined Use of Povidone-Iodine and Rifampicin in Hair Transplantation". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07155408. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*